8-K - Erasca, Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

, the Company makes no admission as to the materiality of Item 7.01 in this report or the presentation available on the Company’s website. The information conta

Regulation Fd

8.01

Other Events. On January 12, 2026, the Company announced clinical progress for its RAS-targeting franchise and 2026-2027 milestones. ERAS-0015 – Potential best

Other Event

9.01

Financial Statements and Exhibits. Exhibit No. Description 99.1 Erasca, Inc. Corporate Presentation - January 2026 104 Cover Page Interactive Data File (embedde

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1